We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPFI:NYSEOppFi Inc. Analysis

Data as of 2026-06-26 - not real-time

$9.36

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

OppFi (OPFI) trades at $9.36, well below its 20‑day SMA of $8.43 and 50‑day SMA of $8.72, yet still under the 200‑day SMA of $9.49, indicating a short‑term bearish bias despite a modest upside to its 200‑day average. The RSI sits at 63, suggesting momentum is still on the upside side of neutral, while the MACD histogram is positive and the signal line is bearish, creating a mixed technical picture. Volatility is high at over 54% for the past 30 days and beta exceeds 1.2, flagging elevated market risk, but the stock’s PE of 4.6 and forward PE of 4.3 are dramatically lower than the industry average of 16.9, positioning OPFI as a deep value play. The DCF‑derived fair value of $24.81 implies roughly a 50% upside, reinforcing the undervalued assessment. Fundamentally, OPFI delivers a strong operating margin of 44.9% and an impressive ROE of 62%, though revenue is contracting at -2.2% YoY. Cash on hand ($63.9 M) comfortably covers a portion of its $295 M debt, but the debt‑to‑equity ratio of 86% signals leverage concerns. The company announced a $130 M acquisition of BNCC Corp and BNC National Bank, projected to be at least 25% EPS‑accretive in year 1 and up to 50% by year 3, with $60‑$115 M in annual cost synergies, providing a clear catalyst for earnings growth. No dividend is paid, so income‑focused investors have no yield benefit. Overall, the combination of a strong valuation discount, upcoming accretive acquisition, and solid profitability is offset by high volatility, leverage, and a bearish technical trend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Mixed technical signals with bearish trend and bullish MACD histogram
  • Upcoming acquisition providing near‑term EPS accretion
  • High volatility and elevated beta increasing price risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Accretive acquisition expected to boost earnings and generate sizable synergies
  • Significant valuation gap versus DCF fair value and industry PE
  • Strong operating margins and ROE supporting profitability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term upside to fair value and continued earnings expansion
  • Strategic geographic expansion from the BNC deal
  • Sustained high profitability despite leveraged balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth-2.20%
Profit Margin19.44%
P/E Ratio4.6
ROE62.06%
ROA26.45%
Debt/Equity86.06
P/B Ratio3.3
Op. Cash Flow$408.3M
Industry P/E16.9

Technical Analysis

TrendBearish
RSI63.0
Support$7.81
Resistance$9.39
MA 20$8.43
MA 50$8.72
MA 200$9.49
MACDBullish
VolumeIncreasing
Fear & Greed Index86.41

Valuation

Fair Value$24.81
Target Price$14.00
Upside/Downside49.57%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.26
Volatility54.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.